Stifel Upgrades Ideaya Biosciences (IDYA) to Buy, Sees Risk/Reward Skewed to the Upside
Tweet Send to a Friend
Stifel analyst Ben Burnett upgraded Ideaya Biosciences (NASDAQ: IDYA) from Hold to Buy with a price target of $20.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
